The ADDoPT (Advanced Digital Design of Pharmaceutical Therapeutics) project is addressing the pharmaceutical industry’s desire to deliver medicines more effectively to patients. ADDoPT is developing and implementing advanced digital design techniques that eliminate non-viable drug candidate formulations as early as possible, streamlining design, development and manufacturing processes.
The ADDoPT project has put a strong emphasis on the industrial application of new and emerging tools for Digital Design and Operation, and the industrial partners have built up experience and an extensive case book of case studies across aREAD MORE
Digital Design Showcase highlights the business case for Digital Twins The ADDoPT project's major showcase event, held on 28th March 2019 at the Clayton Hotel, Chiswick, London provided a vivid demonstration of the range of industry-readyREAD MORE
ADDoPT is a four-year collaboration between pharmaceutical companies, solution providers and academia. Part-funded under the Advanced Manufacturing Supply Chains Initiative (AMSCI) and supported by the Medicines Manufacturing Industry PartnershipREAD MORE
We are pleased to make available a series of short video briefings by researchers who have been pivotal to some of the most exciting results emerging from the ADDoPT project. Each video includes a brief description of the work carried out, whatREAD MORE
We are delighted to report that the quality of ADDoPT post-doctoral research fellow Dr Ioannis Fragkopoulos' efforts to characterize and model particulate systems in pharmaceutical pressure filtration has been recognised with the Prize for bestREAD MORE
ADDoPT partners Perceptive Engineering have recently published a range of brochures detailing training course in advanced process control topics. PERCEPTIVE APC - why, how, when and where Advanced Process Control techniques can beREAD MORE